Article
Ophthalmologists are always looking to broaden their procedure offerings to increase their revenue stream.
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
How COVID-19 shifted ophthalmologist-patient communication
(EyePod) From idea to impact: Navigating ophthalmic innovation
OSRX expands medication sizes and adds direct-to-patient post-op kits
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension